STC Pharmaceuticals

STC Biologics is a boutique biopharmaceutical company and contract development and manufacturing organization (CDMO) based in Newton, Massachusetts. The company specializes in the development of complex biologics, with a particular focus on biosimilars and novel monoclonal antibodies. STC Biologics utilizes its proprietary SPEED platform to accelerate the transition of products from discovery to clinical manufacturing. Their business model combines internal drug development programs with high-end consulting and process development services for external partners. The company's pipeline includes several biosimilar candidates targeting major therapeutic areas such as immunology and ophthalmology.